Multilevel Risk Factors of Electronically Measured Medication Non-Adherence in CML

Avi Leader,Noam Benyamini,Sabina De Geest,Juliet Dreyer, Bronya Calvarysky, Sara Gechler,Alina Amitai,Osnat Yarchovskydolberg,Giora Sharf,Eric Tousset,Opher Caspi,Martin H Ellis,Itai Levi, Anat Gafter Gvili,Pia Raanani

Clinical Lymphoma Myeloma and Leukemia（2015）

引用 0|浏览3

暂无评分

摘要

Medication non-adherence (MNA) to tyrosine kinase inhibitors (TKIs) occurs in around 30% of chronic myeloid leukemia (CML) patients and is associated with adverse outcomes. There are no proven strategies for identifying patients at risk for non-adherence in CML, while data on electronically measured adherence are rare.

查看译文

关键词

medication,risk factors,non-adherence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要